Sensorineural hearing loss is a common finding in early onset type 2 diabetes
Endocrine Practice, 04/16/2012
Lerman–Garber I et al. – Patients with early onset type 2 diabetes (T2DM) and poor glycemic control have an increased prevalence of subclinical hearing loss and impaired auditory brainstem responses. Hearing impairment may be an under–recognized complication of diabetes.
Forty-six consecutive patients with early onset type 2 diabetes (T2DM) and forty-seven age-matched controls with rheumatoid arthritis were included.
All subjects completed clinical, serologic and auditory assessments.
Patients with T2DM had a mean age of 42±6 years and mean disease duration of 11±6 years.
Microalbuminuria was present in 26.1%, symptomatic peripheral neuropathy in 23.9%, and proliferative retinopathy in 26.1%.
The prevalence of unilateral or bilateral hearing loss was significantly higher in diabetic rather than in RA patients (21.7% vs. 6.4%, p=0.01).
Most cases were mild and involved high or acute tones.
After multivariate analysis adjusting for age, there was a significant association between hearing loss and HbA1c (OR=1.3, IC95% 1.02-1.81, p=0.035).
In diabetic patients the lengthening of the brainstem response was not significantly increased; however, the wave morphology was abnormal and/or the reproducibility was poor in 28% of the patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.